Edition:
United States

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

27.85USD
16 Feb 2018
Change (% chg)

$0.07 (+0.25%)
Prev Close
$27.78
Open
$27.69
Day's High
$28.71
Day's Low
$27.69
Volume
115,854
Avg. Vol
139,916
52-wk High
$28.96
52-wk Low
$11.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 24.14 -0.277
Jun '17 8.75 -0.686
Mar '17 11.65 -0.226
FY 2016 Dec '16 6.27 -0.385
Sep '16 3.45 -0.404
Jun '16 3.09 -0.393
Mar '16 2.22 -0.444
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 4 18.53 25.80 14.73 --
Quarter Ending Jun-18 4 18.58 26.00 14.73 --
Year Ending Dec-18 7 67.91 104.60 44.11 51.37
Earnings (per share)
Quarter Ending Mar-18 4 -0.22 -0.01 -0.33 --
Quarter Ending Jun-18 4 -0.27 -0.08 -0.38 --
Year Ending Dec-18 8 -1.71 -0.42 -3.00 -2.77
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.11 34.43
P/E High - Last 5 Yrs. -- 280.23 46.75
P/E Low - Last 5 Yrs. -- 91.71 24.14
Beta -- 0.82 0.81
Price to Sales (TTM) 21.05 140.57 8.57
Price to Book (MRQ) 22.72 18.76 5.14
Price to Tangible Book (MRQ) 24.94 25.38 6.30
Price to Cash Flow (TTM) -- 118.58 25.75
% Owned Institutions 94.05 12.07 2.33

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.27
Payout Ratio(TTM) -- 9.21 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 599.02 43.07 9.45
Sales (TTM) vs TTM 1 Yr. Ago 372.36 45.64 7.30
Sales - 5 Yr. Growth Rate -- 32.43 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 31.29 0.41 20.15
EPS (TTM) vs TTM 1 Yr. Ago 3.47 -- --
EPS - 5 Yr. Growth Rate -- 44.88 11.48
Capital Spending - 5 Yr. Growth Rate -- 41.98 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.78 2.42
Current Ratio (MRQ) 5.28 6.17 3.38
LT Debt to Equity (MRQ) 0.00 16.64 11.85
Total Debt to Equity (MRQ) 0.00 18.80 15.12
Interest Coverage (TTM) -- -165.32 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 50.23 54.90
Gross Margin - 5 Yr. Avg. -- 55.34 52.64
EBITD Margin (TTM) -113.16 -- --
EBITD - 5 Yr. Avg -- -567.40 9.86
Operating Margin (TTM) -116.57 -697.09 1.25
Operating Margin - 5 Yr. Avg. -- -588.12 5.07
Pre-Tax Margin (TTM) -113.68 -664.73 2.12
Pre-Tax Margin - 5 Yr. Avg. -- -596.31 5.33
Net Profit Margin (TTM) -113.64 -659.23 -1.38
Net Profit Margin - 5 Yr. Avg. -- -600.20 1.62
Effective Tax Rate (TTM) -- 1.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 18.11 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 651,551 23,305,201 819,569,446
Net Income/Employee (TTM) -740,423 -626,600 95,804,981
Receivable Turnover (TTM) 2.50 15.04 5.40
Inventory Turnover (TTM) -- 2.52 3.48
Asset Turnover (TTM) 0.18 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -19.92 -1.27 10.68
Return on Assets - 5 Yr. Avg. -- -0.48 12.00
Return on Investment (TTM) -23.82 -1.15 13.54
Return on Investment - 5 Yr. Avg. -- 2.13 15.72
Return on Equity (TTM) -85.62 -20.84 14.80
Return on Equity - 5 Yr. Avg. -- -2.48 16.91
  1 Year 3 Year 5 Year
Sales % 95.06 156.83 --
EPS (TTM) % 66.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CytomX Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 9.00 12.12 78 71
13 Week 37.12 29.43 80 93
26 Week 105.84 82.74 89 86
52 Week 139.67 105.90 87 87
YTD 31.93 29.10 83 90
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 94.05%
# of Holders: 179
Total Shares Held: 36,123,755
3 Mo. Net Change: 5,783,416
# New Positions: 41
# Closed Positions: 14
# Increased Positions: 104
# Reduced Positions: 50
# Net Buyers: 54
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.